In the first quarter of 2025, Gpi signed new international contracts worth approximately €15 million, confirming its upward trajectory in global markets.
Year-on-year growth of 67% highlights the effectiveness of the Group’s strategy, which continues to capitalize on the global demand for innovation in digital healthcare.
Software remains the main growth driver this quarter, with signed contracts totaling €14 million—up 75% compared to Q1 2024. A standout contributor was the Gpi4Med.BLOOD Suite, which secured nearly €5 million in new agreements.
The rest of the Gpi4Med Suite also performed well, recording a 16% annual increase. The Automation division remained steady, closing new contracts worth €800,000, in line with last year.
These results strengthen Gpi’s global presence and underline the value of synergies across the Group, supporting the entire digital healthcare value chain.
